Home›Companies›Carlsmed

Carlsmed, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 7, 2025·Suggest an edit

About Carlsmed

Carlsmed is a private company based in Carlsbad, California. It has reported $109,119,465 raised in four offerings on Form D since November 2019. Its chief executive is Michael Cordonnier.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 12, 2024Mar 21, 2024amended Feb 7, 2025$64,499,995fully sold7$9.2MEquityRule 506(b)Form D/A ↗1 earlier filing
Apr 18, 2022Apr 27, 2022$29,999,990fully sold21$1.4MEquityRule 506(b)Form D ↗
Dec 15, 2020Dec 17, 2020$12,634,480of $12.6M target50$252KEquity, Securities on exerciseRule 506(b)Form D ↗
Nov 4, 2019Nov 19, 2019amended May 15, 2020$1,985,000of $2.4M target40$49,625DebtRule 506(b)Form D/A ↗1 earlier filing
Total, four offerings$109,119,465

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Carlsmed's Form D filed Feb 7, 2025.

KB
LG
Leonard Greenstein
Executive officer
DS
Durall Scott
Executive officer
NC
Niall Casey
Executive officer and director
PY
Philip Young
Director
MC
Michael Cordonnier
Chief Executive Officer and director
KS
Kevin Sidow
Director
SS
Sharon Schulzki
Executive officer
SH
Shariq Hussain
Executive officer
JR
Jonathan Root
Director
Also a director at Okami Medical and Route 92 Medical.

Earlier filings also listed Mark Singer (executive officer, last listed Apr 2022), Alexander Arrow (executive officer, last listed Apr 2022), Justin Esterberg (executive officer, last listed Dec 2020), Jonathon Root (director, last listed Dec 2020) and Jeffrey Roh (director, last listed May 2020).

Sources

  1. SECCARLSMED, INC. Form D, filed Mar 21, 2024
  2. SECCARLSMED, INC. Form D, filed Nov 19, 2019
  3. SECCARLSMED, INC. filing history